D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 97 Citations 32,535 752 World Ranking 822 National Ranking 371
Biology and Biochemistry D-index 103 Citations 36,880 731 World Ranking 910 National Ranking 572

Research.com Recognitions

Awards & Achievements

1998 - Ernest Guenther Award, American Chemical Society (ACS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Organic chemistry
  • Biochemistry
  • Enzyme

George R. Pettit mostly deals with Stereochemistry, Biochemistry, Combretastatin, Tubulin and Bryostatin 1. His Stereochemistry study combines topics in areas such as Biological activity, In vitro and Cell culture, Human cancer. George R. Pettit interconnects Prodrug and Chemical synthesis in the investigation of issues within Combretastatin.

His work deals with themes such as Vinblastine, Natural product, Mitosis and Colchicine, which intersect with Tubulin. His studies deal with areas such as Bryostatin, Molecular biology, Pharmacology and Protein kinase A as well as Bryostatin 1. His Cell growth study integrates concerns from other disciplines, such as Inhibitory postsynaptic potential and Botany.

His most cited work include:

  • Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4 (598 citations)
  • Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature (589 citations)
  • Isolation and Structure of Bryostatin 1 (495 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Stereochemistry, Organic chemistry, Biochemistry, Cell culture and Bryostatin 1. His Stereochemistry research incorporates themes from Sponge, Combretastatin, Human cancer, Biological activity and Chemical synthesis. His study looks at the relationship between Combretastatin and topics such as Prodrug, which overlap with Phosphate.

His research in Biochemistry tackles topics such as Tubulin which are related to areas like Vinblastine. His research integrates issues of Cancer cell, Cell growth and Cytotoxicity in his study of Cell culture. The concepts of his Bryostatin 1 study are interwoven with issues in Bryostatin, Molecular biology, Immunology and Pharmacology.

He most often published in these fields:

  • Stereochemistry (42.92%)
  • Organic chemistry (16.23%)
  • Biochemistry (16.34%)

What were the highlights of his more recent work (between 1999-2020)?

  • Stereochemistry (42.92%)
  • Biochemistry (16.34%)
  • Combretastatin (8.17%)

In recent papers he was focusing on the following fields of study:

Stereochemistry, Biochemistry, Combretastatin, Prodrug and Chemical synthesis are his primary areas of study. His biological study spans a wide range of topics, including Cell culture, Cell growth, Sponge and Biological activity, Pharmacognosy. In Biochemistry, he works on issues like Cancer cell, which are connected to Growth inhibition and Growth inhibitory.

George R. Pettit works mostly in the field of Combretastatin, limiting it down to topics relating to Pharmacology and, in certain cases, In vivo, as a part of the same area of interest. His Prodrug research is multidisciplinary, incorporating elements of Medicinal chemistry, Phosphate, Organic chemistry, Sodium and Combinatorial chemistry. His Chemical synthesis research incorporates elements of Wittig reaction, Stereoisomerism, Ether, Structure–activity relationship and Narciclasine.

Between 1999 and 2020, his most popular works were:

  • Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent (340 citations)
  • Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing (245 citations)
  • Density functional study on the structural conformations and intramolecular charge transfer from the vibrational spectra of the anticancer drug combretastatin‐A2 (193 citations)

In his most recent research, the most cited papers focused on:

  • Organic chemistry
  • Enzyme
  • Biochemistry

His primary areas of investigation include Stereochemistry, Combretastatin, Biochemistry, Biological activity and Chemical synthesis. George R. Pettit interconnects Tubulin, Pharmacognosy and Cell growth in the investigation of issues within Stereochemistry. His Combretastatin study incorporates themes from Prodrug, Pharmacology, Resveratrol, Phosphate and In vivo.

His Biochemistry study combines topics from a wide range of disciplines, such as Mitosis and Cell biology. His Biological activity research is multidisciplinary, relying on both Cancer cell, Combretum caffrum, Benzophenone and Cis–trans isomerism. His Chemical synthesis research incorporates themes from Wittig reaction, Combretastatin A-4, Cytotoxicity, Structure–activity relationship and Amine gas treating.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

George Pettit;S. B. Singh;E. Hamel;C. M. Lin.
Cellular and Molecular Life Sciences (1989)

905 Citations

Isolation and Structure of Bryostatin 1

George R. Pettit;Cherry L. Herald;Dennis L. Doubek;Delbert L. Herald.
Journal of the American Chemical Society (1982)

755 Citations

Tumor inhibiting tetrapeptide bearing modified phenethyl amides

Pettit George R;Barkoczy Jozsef.
(1993)

746 Citations

The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10

George R. Pettit;Yoshiaki Kamano;Cherry L. Herald;Albert A. Tuinman.
Journal of the American Chemical Society (1987)

742 Citations

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Graham G. Dark;Sally A. Hill;Vivien E. Prise;Gillian M. Tozer.
Cancer Research (1997)

721 Citations

Elucidation and synthesis of selected pentapeptides

Pettit George R;Srirangam Jayaram K.
(1994)

702 Citations

Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin

Chii M. Lin;Holly H. Ho;George R. Pettit;Ernest Hamel.
Biochemistry (1989)

588 Citations

Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent

L. Meijer;A. M W H Thunnissen;A. W. White;M. Garnier.
Chemistry & Biology (2000)

562 Citations

Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6

George R. Pettit;Sheo Bux Singh;Michael R. Boyd;Michael R. Boyd;Ernest Hamel;Ernest Hamel.
Journal of Medicinal Chemistry (1995)

508 Citations

Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides

Darko Kantoci;R. George Pettit;K. Jayaram Srirangam.
(1995)

445 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing George R. Pettit

Ernest Hamel

Ernest Hamel

National Institutes of Health

Publications: 118

Peter M. Blumberg

Peter M. Blumberg

National Institutes of Health

Publications: 75

Paul A. Wender

Paul A. Wender

Stanford University

Publications: 54

Ian Paterson

Ian Paterson

University of Cambridge

Publications: 40

Amos B. Smith

Amos B. Smith

University of Pennsylvania

Publications: 40

Laurent Meijer

Laurent Meijer

Perha Pharmaceuticals

Publications: 38

Romeo Romagnoli

Romeo Romagnoli

University of Ferrara

Publications: 37

William H. Gerwick

William H. Gerwick

University of California, San Diego

Publications: 36

Enrique Rozengurt

Enrique Rozengurt

University of California, Los Angeles

Publications: 36

Jaume Bastida

Jaume Bastida

University of Barcelona

Publications: 32

Gianni Marone

Gianni Marone

University of Naples Federico II

Publications: 30

Kuo Hsiung Lee

Kuo Hsiung Lee

China Medical University

Publications: 30

Jang Yang Chang

Jang Yang Chang

National Health Research Institutes

Publications: 30

Jean-Daniel Brion

Jean-Daniel Brion

Centre national de la recherche scientifique, CNRS

Publications: 28

Daniel L. Alkon

Daniel L. Alkon

West Virginia University

Publications: 27

Marcelo G. Kazanietz

Marcelo G. Kazanietz

University of Pennsylvania

Publications: 27

Trending Scientists

Ping Liu

Ping Liu

University of California, San Diego

Guoxiong Wang

Guoxiong Wang

Dalian Institute of Chemical Physics

Jonathan Chernoff

Jonathan Chernoff

Fox Chase Cancer Center

Thomas N. Buckley

Thomas N. Buckley

University of California, Davis

Giulio Draetta

Giulio Draetta

The University of Texas MD Anderson Cancer Center

Haruhiko Sugimura

Haruhiko Sugimura

Hamamatsu University

Neville E. Sanjana

Neville E. Sanjana

New York University

Maki Kondo

Maki Kondo

National Institute for Basic Biology

Luis Miguel Ortega-Mora

Luis Miguel Ortega-Mora

Complutense University of Madrid

Patrice de Caritat

Patrice de Caritat

Geoscience Australia

Xiaoqi Huang

Xiaoqi Huang

Sichuan University

Paul U. Cameron

Paul U. Cameron

University of Melbourne

Bernhard Hemmer

Bernhard Hemmer

Technical University of Munich

Jude Cassidy

Jude Cassidy

University of Maryland, College Park

Steven Z. George

Steven Z. George

Duke University

George B. McDonald

George B. McDonald

University of Washington

Something went wrong. Please try again later.